Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-09-21
1998-01-27
Chambers, Jasemine C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 43, 514 45, 514 46, 514 47, 424450, A61K 4800, C12N 500, C12N 1500, C07N 1400
Patent
active
057122563
ABSTRACT:
The present invention comprises compositions and preparations for the promotion of wound healing in an animal. Methods for preparing the compositions as well as methods for using the compositions to achieve the promotion of wound healing are also provided. Methods for enhancing collagen production at a wound site are also disclosed. The composition may comprise a dietary regimen or a therapeutic agent. These compositions include a wound healing promoting concentration of ribonucleotides in a pharmaceutically acceptable carrier solution. By way of example, such ribonucleotides may comprise RNA, adenine, uracil or a mixture thereof. The compositions can be prepared as suitable for oral, parenteral, intravenous or topical administration. Methods for using the preparation as a treatment to enhance the healing of an already existing wound or for use as a pretreatment regimen for animals in anticipation of surgery, are also disclosed.
REFERENCES:
patent: 4308257 (1981-12-01), Caspe
patent: 4486439 (1984-12-01), Studt et al.
patent: 4912092 (1990-03-01), Gruber
patent: 4994442 (1991-02-01), Gil et al.
patent: 5066500 (1991-11-01), Gil et al.
patent: 5246708 (1993-09-01), von Borstel et al.
Belardinelli et al., "The Cardaic Effects of Adenosine," Progress in Cardiovascular Diseases, XXXII(1):73-97, 1989.
DeLucchi et al., "Effects of Dietary Nucleotides on the Fatty Acid Composition of Erythrocyte Membrane Lipids in Term Infants," Journal of Pediatric Gastroenterology and Nutrition, 6:568-574, 1987.
Fanslow et al., "Effect of Nucleotide Restriction and Supplementation on Resistance to Experimental Murine Candidiasis," Journal of Parenteral and Enteral Nutrition, 12(1) :49-52, 1988.
Kulkarni et al., "Influence of Dietary Nucleotide Restriction on Bacterial Sepsis and Phagocytic Cell Function in Mice," Arch Surg., 121:169-172, 1986.
Kulkarni et al., "Modulation of Delayed Hypersensitivity in Mice by Dietary Nucleotide Restriction," Transplantation, 44(6) :847-849, 1987.
Kulkarni et al., "Immunohemopoietic Effects of Dietary Nucleotide Restriction in Mice," Transplantation, 53(2) :467-472, 1992.
Pizzini et al., "Dietary Nucleotides Reverse Malnutrition and Starvation-Induced Immunosuppression," Arch Surg., 125:86-90, 1990.
Rudolph et al., "Role of RNA as a Dietary Source of Pyrimidines and Purines in Immune Function," Symposium Proceedings, Supplement to Nutrition, 6(1):45-52, 1990.
Van Buren et al., "Dietary Nucleotides, A Requirement for Helper/Inducer T Lymphocytes," Transplantation, 40(6) :694-697, 1985.
Wyatt et al., "Adenosine Stimulates Glycolytic Flux in Isolated Perfused Rat Hearts by A1-Adenosine Receptors," American Journal of Physiology257 (Heart Circ. Physiol.26) :H1952-H1957, 1989.
European Search Report PCT/US94/07376, filed 30 Jun. 1994.
Sigma Chemical Company, "Biochemicals Organic Compounds for Research and Diagnostic Reagents," published 1992 by Sigma Chemical Co., pp. 42-55, 888-891, 958-961, 1462, 1511, 1521, 1729-1733, 1736, 1737 and 1740.
Wyngaarden et al., "Cecil Textbook of Medicine," published 1988 by W.B. Saunders (Philadelphia, PA), pp. 1980-1984.
Daly, JM et al., "Enteral Nutrition with Supplemental . . . ", Surgery 112 (1): 56-67 (1992).
Kulkarni Anil D.
Rudolph Frederick B.
Van Buren Charles T.
Board of Regents , The University of Texas System
Chambers Jasemine C.
Clark Deborah J.R.
William Marsh Rice University
LandOfFree
Ribonucleotide preparations and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ribonucleotide preparations and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ribonucleotide preparations and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-342368